Lymphoma
Showing 51 - 75 of 1,788
Lymphoma, Relapsed/Refractory T-cell Lymphomas Trial in United States (Romidepsin, Bortezomib, duvelisib)
Active, not recruiting
- Lymphoma
- Relapsed/Refractory T-cell Lymphomas
- Romidepsin
- +2 more
-
Stanford, California
- +10 more
Feb 2, 2023
Lymphoma, Non-Hodgkin Lymphoma, NHL Trial run by the National Cancer Institute (NCI) (Vysis LSI MYC Break Apart Rearrangement
Recruiting
- Lymphoma
- +4 more
- Vysis LSI MYC Break Apart Rearrangement Probe Kit
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Cognitive Aftereffects of Neurotoxicity in Children and Young
Not yet recruiting
- Lymphoma
- Leukemia
-
Los Angeles, California
- +2 more
Feb 2, 2023
Follow-up Protocol for Patients With Cancer/AIDS/Skin Disease
Active, not recruiting
- Melanoma
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 31, 2023
FUR to Quantify Tumor Glucose Consumption in Oncologic PET
Not yet recruiting
- Lung Cancer
- Lymphoma
- FDG PET/CT
-
Maastricht, Limburg, NetherlandsAcademisch ziekenhuis Maastricht
Jan 31, 2023
Multiple Myeloma, MDS, Diffuse Large B Cell Lymphoma Trial in Denmark (Advance consultation concerning your life and treatment
Recruiting
- Multiple Myeloma
- +3 more
- Advance consultation concerning your life and treatment (ACT )
-
Aalborg, Denmark
- +6 more
Jan 31, 2023
Assessing the Presence of CT-DNA in Lymphoma Associated HLH
Not yet recruiting
- Lymphoma
- Haemophagocytic Lymphohistiocytosis
- (no location specified)
Jan 25, 2023
Hematologic Malignancy, Blood Cancer, Lymphoma Trial in Boston (Palliative Care, Usual Care)
Recruiting
- Hematologic Malignancy
- +4 more
- Palliative Care
- Usual Care
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Jan 24, 2023
Epstein-Barr Virus Infections, Lymphoma, Lymphoproliferative Disorder Trial run by the NCI (Nivolumab)
Recruiting
- Epstein-Barr Virus Infections
- +3 more
- Nivolumab
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 24, 2023
Solid Tumor, Lymphoma Trial in Israel, United States (MK-2118 (IT), MK-2118 (SC), Pembrolizumab)
Completed
- Solid Tumor
- Lymphoma
- MK-2118 (IT)
- +2 more
-
La Jolla, California
- +7 more
Jan 23, 2023
Leukemia, Lymphoma, Cardiotoxicity Trial in Philadelphia
Completed
- Leukemia
- +4 more
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Jan 19, 2023
Bone Marrow Cancer, Leukemia, Lymphoma Trial in Philadelphia (Virtual reality, Environmental changes)
Enrolling by invitation
- Bone Marrow Cancer
- +4 more
- Virtual reality
- Environmental changes
-
Philadelphia, PennsylvaniaThomas Jefferson University Hospital
Jan 9, 2023
Leukemia, Lymphoma Trial in United States (SCRI-CAR22v2)
Recruiting
- Leukemia
- Lymphoma
- SCRI-CAR22v2
-
Los Angeles, California
- +4 more
Jan 18, 2023
Solid Tumor Malignancy, Hematologic Malignancy, Leukemia Trial run by the NCI (mrna 1273 injection)
Recruiting
- Solid Tumor Malignancy
- +4 more
- mRNA-1273
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 14, 2023
Ovarian Reserve in Younger Newly Diagnosed Lymphomas
Active, not recruiting
- Anaplastic Large Cell Lymphoma
- +4 more
- Laboratory Biomarker Analysis
- Questionnaire Administration
-
Birmingham, Alabama
- +106 more
Jan 11, 2023
Lymphoma, Autologous Hematopoietic Stem Cell Transplantation Trial in Xi'an (Improved BEAM regimen)
Not yet recruiting
- Lymphoma
- Autologous Hematopoietic Stem Cell Transplantation
- Improved BEAM regimen
-
Xi'an, Shaanxi, ChinaFirst Affiliated Hospital of Xi'an Jiaotong University
Dec 26, 2022
